Considering there has been commentary on the PNV threads about PNV sales slowing down due to poor access during COVID and reduced elective surgeries, then how the various countries that PNV sells in are dealing with, and emerging from, the pandemic is highly relevant.
The fact that PNV has had solid growth despite the hurdles of 2020 and 2021, is a good indicator that there will be stronger sales growth as the effects recede and the pace of the growth acceleration is very reliant on one of our major markets;the US.
Australia is an excellent proxy for what will happen as the USA hospitals in various regions begin to see stable cases as vaccinations protect more of the population.
Ann: H1 FY21 Results Investor Presentation, page-334
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.57 |
Change
-0.040(1.53%) |
Mkt cap ! $1.794B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.57 | $897.0K | 344.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 18135 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 16019 | 24 |
View Market Depth
| Last trade - 15.01pm 19/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |